Subscribe To
SXTP / Why Is 60 Degrees Pharmaceuticals (SXTP) Stock Up 17% Today?
SXTP News
By GlobeNewsWire
October 19, 2023
60 Degrees Pharma to Present Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting in Boston
60 Degrees Pharma Presents Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meetin more_horizontal
By GlobeNewsWire
September 6, 2023
60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conference
WASHINGTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals Inc. (“60P” or the “Company”) (Nasdaq: SXTP ), a pharmaceutical comp more_horizontal
By InvestorPlace
July 13, 2023
Why Is 60 Degrees Pharmaceuticals (SXTP) Stock Up 17% Today?
60 Degrees Pharmaceuticals (NASDAQ: SXTP ) stock is on the rise Thursday following the company's public debut yesterday. The public launch of SXTP sto more_horizontal